Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

José A Apud

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Pharmacological Research|June 21, 2011
The extraction, isolation and purification of an endogenous regulator for the 5-HT2 receptorJosé A Apud
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2006
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugsJosé A Apud, Daniel R Weinberger
CNS Drugs|June 21, 2007
Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitorsJosé A Apud, Daniel R Weinberger
Journal of Abnormal Psychology|January 19, 2012
Using latent class growth analysis to form trajectories of premorbid adjustment in schizophreniaVeronica T Cole, José A Apud, Daniel R Weinberger, et al.
The American Journal of Psychiatry|June 19, 2012
Genetic variation in KCNH2 associated with expression in the brain of a unique hERG isoform modulates treatment response in patients with schizophreniaJosé A Apud, Fengyu Zhang, Heather Decot, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 18, 2014
Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophreniaAaron Jenkins, José A Apud, Fengyu Zhang, et al.
Schizophrenia Research. Cognition|November 25, 2021
Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive abilityRachael K Blackman, Dwight Dickinson, Daniel P Eisenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2009
Cognitive fitness of cost-efficient brain functional networksDanielle S Bassett, Edward T Bullmore, Andreas Meyer-Lindenberg, et al.
Brain : a Journal of Neurology|July 20, 2010
Handedness, heritability, neurocognition and brain asymmetry in schizophreniaAmy Deep-Soboslay, Thomas M Hyde, Joseph P Callicott, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 8, 2017
Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free ConditionsDaniel Paul Eisenberg, Lisa Yankowitz, Angela M Ianni, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Pharmacological Research|June 21, 2011
The extraction, isolation and purification of an endogenous regulator for the 5-HT2 receptorJosé A Apud
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2006
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugsJosé A Apud, Daniel R Weinberger
CNS Drugs|June 21, 2007
Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitorsJosé A Apud, Daniel R Weinberger
Journal of Abnormal Psychology|January 19, 2012
Using latent class growth analysis to form trajectories of premorbid adjustment in schizophreniaVeronica T Cole, José A Apud, Daniel R Weinberger, et al.
The American Journal of Psychiatry|June 19, 2012
Genetic variation in KCNH2 associated with expression in the brain of a unique hERG isoform modulates treatment response in patients with schizophreniaJosé A Apud, Fengyu Zhang, Heather Decot, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 18, 2014
Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophreniaAaron Jenkins, José A Apud, Fengyu Zhang, et al.
Schizophrenia Research. Cognition|November 25, 2021
Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive abilityRachael K Blackman, Dwight Dickinson, Daniel P Eisenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2009
Cognitive fitness of cost-efficient brain functional networksDanielle S Bassett, Edward T Bullmore, Andreas Meyer-Lindenberg, et al.
Brain : a Journal of Neurology|July 20, 2010
Handedness, heritability, neurocognition and brain asymmetry in schizophreniaAmy Deep-Soboslay, Thomas M Hyde, Joseph P Callicott, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 8, 2017
Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free ConditionsDaniel Paul Eisenberg, Lisa Yankowitz, Angela M Ianni, et al.
Pageof 2